United States · FDA National Drug Code directory

INSULIN GLARGINE

Source ingredient · 23 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0002-7715_32977bea-c837-4acc-b469-03a2fc765787

BASAGLAR KwikPen

INJECTION, SOLUTION / Eli Lilly and Company

United States · Source reference 72572-422_83f8663d-cb21-9b78-e315-e0db15befb18

INSULIN GLARGINE

INJECTION, SOLUTION / Civica, Inc.

United States · Source reference 72572-424_40be8473-6e6e-3d64-cb3d-5f8060a262f3

INSULIN GLARGINE

INJECTION, SOLUTION / Civica, Inc.

United States · Source reference 63083-1556_c3c5ae59-b449-474d-8b9c-80f1e5e4eb7b

Insulin 1556

LIQUID / Professional Complementary Health Formulas

United States · Source reference 83257-014_1788fd3f-09d7-eb86-5e9e-db823fa41a8a

Insulin Glargine

INJECTION, SOLUTION / Biocon Biologics Inc.

United States · Source reference 83257-015_1788fd3f-09d7-eb86-5e9e-db823fa41a8a

Insulin Glargine

INJECTION, SOLUTION / Biocon Biologics Inc.

United States · Source reference 0955-3900_63c52b96-0bdf-42f0-9c6c-e439846e6926

Insulin glargine U-300

INJECTION, SOLUTION / Sanofi-Aventis U.S. LLC

United States · Source reference 0955-2900_63c52b96-0bdf-42f0-9c6c-e439846e6926

Insulin glargine U-300 Max

INJECTION, SOLUTION / Sanofi-Aventis U.S. LLC

United States · Source reference 87682-090_55fe4d38-f4dd-bde7-e063-6394a90a44ba

LANGLARA

INJECTION, SOLUTION / Lanexa Biologics, LLC

United States · Source reference 50090-4068_0d876768-7216-4d1a-b54a-704989ec10bb

LANTUS SOLOSTAR

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 0088-2220_4e220385-b760-4a64-a1ca-84bd2bebe448

Lantus

INJECTION, SOLUTION / sanofi-aventis U.S. LLC

United States · Source reference 50090-0876_36965dca-e4e9-465f-a209-bb5f76739989

Lantus

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 0088-2219_4e220385-b760-4a64-a1ca-84bd2bebe448

Lantus Solostar

INJECTION, SOLUTION / sanofi-aventis U.S. LLC

United States · Source reference 50090-1398_577365d4-f4cb-4431-9b05-a3d90efb7856

Lantus Solostar

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 50090-6439_68a9b7e3-8bf4-4e52-a853-9b30b906e314

REZVOGLAR KWIKPEN

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 0002-8980_a9e95b4c-e280-4bef-a3dd-4907bfad6b4d

Rezvoglar KwikPen

INJECTION, SOLUTION / Eli Lilly and Company

United States · Source reference 83257-011_3b749417-8933-850b-1373-990e7ee8a312

SEMGLEE

INJECTION, SOLUTION / Biocon Biologics Inc.

United States · Source reference 83257-012_3b749417-8933-850b-1373-990e7ee8a312

SEMGLEE

INJECTION, SOLUTION / Biocon Biologics Inc.

United States · Source reference 0024-5761_dd3cca75-32f2-4e6d-8121-20f47e101495

Soliqua 100/33

INJECTION, SOLUTION / Sanofi-Aventis U.S. LLC

United States · Source reference 0024-5869_49201ad7-68f7-407c-959f-852591703f96

TOUJEO

INJECTION, SOLUTION / Sanofi-Aventis U.S. LLC

United States · Source reference 50090-2193_cab55702-5aa0-48a9-9989-36255bffb0e4

TOUJEO

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 0024-5871_49201ad7-68f7-407c-959f-852591703f96

TOUJEO Max

INJECTION, SOLUTION / Sanofi-Aventis U.S. LLC

United States · Source reference 50090-4177_49a2c875-471e-4f82-90bd-b6997234d4e6

TOUJEO Max

INJECTION, SOLUTION / A-S Medication Solutions

Browse ingredients in United States